Last Updated -
August 5, 2026
Explore the business model, global strategy, and market performance including insights into its position in China.
Unitree Robotics, legally Unitree Technology Co., Ltd., is a robotics company founded in 2016 and headquartered in Hangzhou, China. It designs, manufactures and sells legged robots, humanoid robots, dexterous robotic arms, and related components and software for consumer, research, industrial and commercial users. Its products include Go-series quadrupeds for developers and education, industrial quadrupeds such as A-series and B-series models, and humanoid platforms including G1, H1, H2 and R1.
The company has developed from a specialist in high-performance quadruped robots into one of China’s most visible humanoid and embodied-AI robotics companies. Embodied AI refers to artificial intelligence used in physical machines that sense, move and interact with the real world. Unitree emphasizes in-house research and vertical integration across motors, reducers, controllers, perception hardware and motion-control algorithms, which supports rapid product iteration and lower hardware pricing. Its stated strategic focus includes core robotics technologies, intelligent robotics AI models and broader access to advanced robots.
Unitree is private, but by July 2026 it had cleared major regulatory steps for a Shanghai STAR Market IPO. The company reported FY2025 revenue of RMB 1.699 billion, up from RMB 393 million in 2024 and RMB 159 million in 2023, with FY2025 net profit of RMB 278 million and a core-business gross margin of 60.13%. Its prospectus forecast H1 2026 revenue of RMB 1.052 billion to RMB 1.128 billion, and the planned IPO aims to raise about RMB 4.202 billion for technology development and long-term strategy. Unitree’s market relevance is reinforced by its public robot showcases, broad developer and research user base, and NVIDIA’s selection of a Unitree H2 humanoid chassis for an Isaac GR00T reference humanoid robot for academic research.
Unitree Robotics makes money mainly by designing, manufacturing and selling legged robots, humanoid robots, dexterous manipulators and related robotics components. Its model is product-led rather than subscription-led, with revenue tied to robot hardware sales, components and associated robotics platforms for developers, research institutions, industrial users, public-safety customers, entertainment projects and prosumers.
The latest available published financials are FY2025 prospectus figures, with no Q1 2026 results found. Revenue reached RMB 1.699 billion in 2025, up from RMB 393 million in 2024 and RMB 159 million in 2023. Net profit was RMB 278 million in 2025, while adjusted profit excluding non-recurring items was about RMB 590 million to RMB 591 million. The company reported a core-business gross margin of 60.13%. Its prospectus forecast H1 2026 revenue of RMB 1.052 billion to RMB 1.128 billion.
Unitree’s main competitive advantage is its combination of low-cost hardware, fast product iteration and vertical integration. By controlling key components and algorithms internally, the company has reduced manufacturing costs and brought robots to market at prices below many global peers. The G1 humanoid was introduced from RMB 99,000 in 2024, while the R1 lightweight humanoid released in 2025 further lowered the entry point for humanoid hardware.
The company also benefits from strong brand visibility. Its robots have appeared in high-profile public events including the CCTV Spring Festival Gala, the Winter Olympics opening ceremony, the Super Bowl pre-game performance and the Hangzhou Asian Games and Asian Para Games. This visibility has helped position Unitree as one of China’s best-known embodied-AI robotics companies.
Unitree competes with Chinese robotics companies including UBTech Robotics, AgiBot, DEEP Robotics, Leju Robotics and Fourier Intelligence. Global peers include Figure AI, Boston Dynamics and Agility Robotics. Compared with UBTech, which is already publicly listed in Hong Kong and has a broader service-robotics profile, Unitree is more closely associated with high-performance quadrupeds and lower-cost humanoid platforms. Compared with Boston Dynamics, Unitree emphasizes wider public availability and lower price points, while Boston Dynamics is more established in advanced mobility systems and enterprise deployments.
Unitree positions itself as a global leader in publicly retailed high-performance quadruped robots and says it has led global quadruped robot sales over multiple years. In humanoids, it is one of the highest-profile Chinese companies in the field and is moving toward a Shanghai STAR Market listing after its IPO application was accepted in March 2026, passed listing committee review in June 2026 and received Chinese securities regulator approval in July 2026.
The planned IPO would raise about RMB 4.202 billion through the issue of at least 40,446,434 new A-shares. Proceeds are intended for core technology breakthroughs and long-term strategic development, including large AI models for intelligent robotics. If completed, the listing would make Unitree one of the first pure-play humanoid robotics names on China’s A-share market.
China is central to Unitree’s market position. The company is headquartered in Hangzhou, develops and manufactures in China, and benefits from the country’s robotics supply chain, industrial policy support and investor appetite for humanoid robotics. It also has international visibility and overseas research users, but geopolitical scrutiny and procurement restrictions create risks in sensitive foreign markets.
A notable ecosystem validation came from NVIDIA selecting a Unitree H2 humanoid chassis for the NVIDIA Isaac GR00T Reference Humanoid Robot for academic research, with availability from Unitree expected in late 2026. This does not make Unitree a dominant AI software platform, but it indicates that its hardware is relevant to major AI-robotics developers and academic labs.
Unitree’s market position is strong in visibility, cost competitiveness and product breadth, especially in quadrupeds and developer-oriented humanoids. The main investor question is whether the company converts early research, demonstration and developer demand into durable large-scale industrial and commercial deployments while defending margins in a crowded robotics market.
China is Unitree Robotics’ core market. The company is headquartered in Hangzhou, develops and manufactures in China, and is preparing a Shanghai STAR Market IPO after its application was accepted in March 2026, cleared listing committee review in June, and received regulator approval in July. No Q1 2026 results were found, but its prospectus disclosed FY2025 revenue of RMB 1.699 billion, up from RMB 393 million in 2024, and forecast H1 2026 revenue of RMB 1.052 billion to RMB 1.128 billion. Unitree’s China strategy centers on vertically integrated hardware, aggressive pricing, and rapid product iteration across quadrupeds, humanoids, dexterous arms, and components. Local demand comes from research labs, developers, industrial inspection, public-safety, entertainment, and embodied-AI use cases. Key competitors include UBTech Robotics, AgiBot, DEEP Robotics, Leju Robotics, and Fourier Intelligence. Strategic drivers are China’s robotics policy support, deep electronics supply chain, and investor appetite for humanoid robotics listings.
Unitree Robotics entered 2026 with a sharp financial turning point behind it and a potential public listing ahead. The latest full-year figures available are FY2025, when revenue rose to RMB 1.699 billion from RMB 393 million in 2024 and RMB 159 million in 2023. Net profit reached RMB 278 million, compared with a loss in 2023, while adjusted or deducted net profit was reported at about RMB 590 million to RMB 591 million. The company also reported a core-business gross margin of 60.13%. No Q1 2026 results were found, but its prospectus forecast H1 2026 revenue of RMB 1.052 billion to RMB 1.128 billion, implying continued scale-up.
Geographic growth is likely to remain China-led. Unitree benefits from China’s robotics supply chain, policy focus on embodied AI and domestic investor interest in humanoid robotics. International adoption is still important, especially in research and developer markets, but overseas growth faces higher scrutiny in sensitive public-sector, infrastructure and security-related settings.
The near-term outlook depends on IPO completion, continued revenue growth in 2026 and evidence that humanoid products move beyond showcase demand. Unitree has strong momentum, but investors should treat it as an early-stage robotics commercialization story rather than a proven mass-deployment business.
This Company Profile was written by Dominik Diemer
Disclaimer:
All logos are the property of their respective owners and are used for illustrative purposes only.
This site is not affiliated with or endorsed by any of the featured companies.
No Financial Advice.
